Director/PDMR Shareholding

Judges Scientific PLC

29 January 2026

 

29 January 2026

Judges Scientific plc

("Judges Scientific" or the "Company")

Exercise of Options

Judges Scientific announces that David Cicurel, Chief Executive Officer, on 29 January 2026 exercised options over 7,500 new ordinary shares of 5 pence each in the Company ("Ordinary Shares").

Following this exercise David Cicurel is beneficially interested in 551,892 Ordinary Shares and beneficially and non beneficially interested in 618,892 Ordinary Shares, his non beneficial interest comprising 67,000 Ordinary Shares he has gifted to Shoftim Charitable Trust.

Following the above exercise of options, the Company's total issued share capital has increased to 6,660,444 Ordinary Shares. There are no Ordinary Shares held in treasury. Each Ordinary Share carries voting rights on the basis of one vote per Ordinary Share. Therefore, the total number of voting rights in Judges Scientific is 6,660,444 Ordinary Shares. The above figure may be used by shareholders as the denominator for calculations to determine if they have a notifiable interest in Judges Scientific under the Disclosure and Transparency Rules, or if such interest has changed.

For further information please contact: 

Judges Scientific plc David Cicurel, CEO Brad Ormsby, CFO Tel: [phone]	Shore Capital (Nominated Adviser & Joint Broker) Stephane Auton Harry Davies-Ball Tel: [phone]
Panmure Liberum (Joint Broker) Edward Mansfield William King Tel : [phone]	Investec Bank plc (Joint Broker) Virginia Bull Carlton Nelson Tel: [phone]
Alma (Financial Public Relations) Sam Modlin Rebecca Sanders-Hewett Joe Pederzolli Sarah Peters Tel: [phone] [e-mail]

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector.  The Group consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including higher education institutions, scientific research facilities, manufacturers, and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group has received five Queen's Awards for Innovation and Export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the reduction of debt, organic growth, and dividends.

For further information, please visit www.judges.uk.com

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	David Cicurel
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Judges Scientific plc
b)	LEI	2138004EXWWPTW1JOL31
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares in Judges Scientific plc GB0032398678
b)	Nature of the transaction	Exercise of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) 1,402.5p 7,500
d)	Aggregated information - Aggregated volume - Price	N/A (single transaction)
e)	Date of the transaction	29/01/2026
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

 

END